Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Finding Study of S-1, Oxaliplatin, and Irinotecan Combination Chemotherapy for Patients With Inoperable Advanced or Metastatic Gastrointestinal Cancers

NCT01693445 is registered in ClinicalTrials.gov with Hallym University Medical Center as lead sponsor.

NCT NCT01693445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01693445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Finding Study of S-1, Oxaliplatin, and Irinotecan Combination Chemotherapy for Patients With Inoperable Advanced or Metastatic Gastrointestinal Cancers
Lead sponsor
Hallym University Medical Center
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2012
Completion date
August 31, 2014
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal neoplasms